Moderna
MRNA
903 hedge funds and large institutions have $53.9B invested in Moderna in 2021 Q2 according to their latest regulatory filings, with 218 funds opening new positions, 328 increasing their positions, 254 reducing their positions, and 84 closing their positions.
160% more first-time investments, than exits
New positions opened: 218 | Existing positions closed: 84
96% more capital invested
Capital invested by funds: $27.4B → $53.9B (+$26.4B)
88% more funds holding in top 10
Funds holding in top 10: 17 → 32 (+15)
29% more repeat investments, than reductions
Existing positions increased: 328 | Existing positions reduced: 254
16% more funds holding
Funds holding: 776 → 903 (+127)
4.67% more ownership
Funds ownership: 52.41% → 57.08% (+4.7%)
15% less call options, than puts
Call options by funds: $3.96B | Put options by funds: $4.68B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Coatue Management
New York
|
+$873M |
| 2 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
+$713M |
| 3 |
D.E. Shaw & Co
New York
|
+$289M |
| 4 |
Renaissance Technologies
New York
|
+$278M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$270M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$252M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$151M |
| 3 |
JP Morgan Chase
New York
|
-$144M |
| 4 |
Morgan Stanley
New York
|
-$143M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$114M |
MRNA Hedge Fund Activity: Q2 2021 in Review
903 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q2 2021, worth a combined $53.9B — up 96% from $27.4B a quarter earlier.
Buyers outnumbered sellers: 218 funds opened new MRNA positions and 84 closed out — a net gain of 134 holders — while 328 added to existing stakes and 254 trimmed.
The largest buyer was Coatue Management, adding an estimated $873M. The largest seller was BlackRock, cutting an estimated $252M.
- 903 institutional investors held Moderna (MRNA) as of Q2 2021, up from 776 in Q1 2021.
- Funds reported $53.9B of Moderna stock for Q2 2021, up 96% quarter-over-quarter.
- 218 funds opened new Moderna positions in Q2 2021 and 84 closed out, a net change of +134 holders.
- The largest Moderna buyer in Q2 2021 was Coatue Management, an estimated $873M added.
- The largest Moderna seller in Q2 2021 was BlackRock, an estimated $252M sold.
Based on aggregated 13F filings for Q2 2021.